| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/29/2002 | WO2002066633A1 Lectin library |
| 08/29/2002 | WO2002066628A2 Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
| 08/29/2002 | WO2002066621A1 Attenuated live vaccine |
| 08/29/2002 | WO2002066617A1 Method for detecting a risk of hypertension and uses thereof |
| 08/29/2002 | WO2002066615A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066614A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066613A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066612A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066610A2 Hepp, a novel gene with a role in hematopoietic and neural development |
| 08/29/2002 | WO2002066608A2 Virus derived antimicrobial peptides |
| 08/29/2002 | WO2002066607A2 Compositions and methods relating to breast specific genes and proteins |
| 08/29/2002 | WO2002066606A2 Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, hgra4, and splice variant thereof |
| 08/29/2002 | WO2002066605A2 Compositions and methods relating to breast specific genes and proteins |
| 08/29/2002 | WO2002066604A2 Avian mago nashi gene |
| 08/29/2002 | WO2002066603A2 Chemically defined medium for cultured mammalian cells |
| 08/29/2002 | WO2002066601A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam2 |
| 08/29/2002 | WO2002066600A2 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides |
| 08/29/2002 | WO2002066514A2 Artificial fusion proteins with reduced immunogenicity |
| 08/29/2002 | WO2002066513A2 Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof |
| 08/29/2002 | WO2002066511A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 08/29/2002 | WO2002066510A2 Regakine-1 |
| 08/29/2002 | WO2002066508A1 A novel traf6 inhibiting protein |
| 08/29/2002 | WO2002066507A2 Histidine phosphatase interacting protein of 120 kd |
| 08/29/2002 | WO2002066506A2 Use of casb7439 (ash2) in the immunotherapy of breast cancer |
| 08/29/2002 | WO2002066505A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | WO2002066504A2 Protein-protein interactions in saccharomyces cerevisiae |
| 08/29/2002 | WO2002066503A2 H. influenzae antigen basb213 |
| 08/29/2002 | WO2002066502A1 Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
| 08/29/2002 | WO2002066501A2 PROTEIN-PROTEIN INTERACTIONS IN $i(HELICOBACTER PYLORI) |
| 08/29/2002 | WO2002066498A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066488A1 Compositions and methods relating to prostate specific genes and proteins |
| 08/29/2002 | WO2002066076A1 A method of treatment and agents useful for same |
| 08/29/2002 | WO2002066073A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
| 08/29/2002 | WO2002066072A1 Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor |
| 08/29/2002 | WO2002066067A2 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | WO2002066064A1 Use of galanin-like peptide |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002066056A2 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | WO2002066054A1 Vaccine to protect animals against leishmania |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066049A1 Agents for plasmic change |
| 08/29/2002 | WO2002065986A2 Transporters comprising spaced arginine moieties |
| 08/29/2002 | WO2002065985A2 Methods of treating diabetes mellitus |
| 08/29/2002 | WO2002065943A2 Ocular tear growth factor-like protein |
| 08/29/2002 | WO2002050114A3 Modulation of atp-binding cassette transporter activity |
| 08/29/2002 | WO2002050108A3 Immunogenic glycopeptides, screening, preparation and uses |
| 08/29/2002 | WO2002042316A3 Pna analogues |
| 08/29/2002 | WO2002041836A3 Antisense modulation of src-1 expression |
| 08/29/2002 | WO2002038759A3 Method for inducing apoptiosis |
| 08/29/2002 | WO2002036624A3 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof |
| 08/29/2002 | WO2002034930A3 Methods of use of regulators of g-protein signaling to modulate dopamine signaling and dopamine-related neurobehavior |
| 08/29/2002 | WO2002033112A3 Protein-protein interactions in neurodegenerative diseases |
| 08/29/2002 | WO2002030950A3 Haplotypes of the fy gene |
| 08/29/2002 | WO2002030949A3 Haplotypes of the ltb4r gene |
| 08/29/2002 | WO2002020797A3 Genes encoding polypeptides from methylomonas sp. involved exopolysaccharide production |
| 08/29/2002 | WO2002020786A3 Kinase d interacting protein |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002018622A3 TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b) |
| 08/29/2002 | WO2002016426A3 Coaster, a human coactivator of steroid receptors |
| 08/29/2002 | WO2002016396A8 Mammalian rh type b glycoprotein ion transporter |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002010366A3 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 08/29/2002 | WO2002004018A3 Mid-life vaccine and methods for boosting anti-mycobacterial immunity |
| 08/29/2002 | WO2002003917A3 Alphavirus vectors and virosomes with modified hiv genes for use as vaccines |
| 08/29/2002 | WO2002002620A3 Crmp-5 (collapsin response-mediator protein) encoding nucleic acid, polypeptide and uses thereof |
| 08/29/2002 | WO2002002601A3 Mutant presenilin 1 and presenilin 2 polypeptides |
| 08/29/2002 | WO2002000836A3 Spinigerin variants, an antibacterial and antifungal peptide derived from pseudacanthotermes spiniger, preparation method and compositions containing same |
| 08/29/2002 | WO2001094394A3 Plant ubiquitin promoter sequences and methods of use |
| 08/29/2002 | WO2001094388A3 Zcys6: a member of the cystatin superfamily |
| 08/29/2002 | WO2001090343A3 Nucleotide sequences encoding ramosa 1 gene and methods of use for same |
| 08/29/2002 | WO2001090157A3 98p7c3: homeodomain protein highly expressed in various cancers |
| 08/29/2002 | WO2001088135A3 G-protein coupled receptor proteins and nucleic acids encoding same |
| 08/29/2002 | WO2001087930A3 Human galanin receptor-like g protein coupled receptor |
| 08/29/2002 | WO2001087239A3 Methods of affecting laminin 5 processing |
| 08/29/2002 | WO2001085944A3 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 08/29/2002 | WO2001083751A3 Methods for binding an exogenous molecule to cellular chromatin |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001081406A3 Single-chain fertility hormones with variable lh activity |
| 08/29/2002 | WO2001079496A3 Ligand for herpes simplex virus entry mediator and methods of use |
| 08/29/2002 | WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform |
| 08/29/2002 | WO2001079272A3 Sitosterolemia susceptibility gene (ssg): compositions and methods of use |
| 08/29/2002 | WO2001077355A3 Signal transduction stress-related proteins and use in plants |
| 08/29/2002 | WO2001070816A3 Ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | WO2001068858A3 Human g protein-coupled receptors |
| 08/29/2002 | WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | WO2001053453A8 Novel bone marrow nucleic acids and polypeptides |
| 08/29/2002 | WO2001042462A9 Phospholipase a2 inhibitory peptides from python reticulatus |
| 08/29/2002 | WO2001040293A9 Method of modulating proapoptotic and antiapoptotic pathways in cells |
| 08/29/2002 | WO2001027296A9 Regulatory region of a lipid transfer protein (ltpw1) from aleuron tissue of wheat |
| 08/29/2002 | WO2001016174A9 Induction of cytotoxic t lymphocyte response by hla class ia restricted epitopes of mycobacterial heat shock protein 65 |
| 08/29/2002 | WO2001007481A9 Antitumor antibodies, proteins, and uses thereof |
| 08/29/2002 | WO2001005427A9 Psca: prostate stem cell antigen and uses thereof |
| 08/29/2002 | WO2000068382A9 PrP-LIKE GENE |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000063245A9 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 08/29/2002 | WO2000061788A3 Poly(dipeptide) as a drug carrier |
| 08/29/2002 | WO2000061606A9 Novel human voltage-gated potassium channel |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000036101A3 An atp-binding cassette protein responsible for cytotoxin resistance |